Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-30

Clinical Trial Update: Sevoflurane Induced Emergence Agitation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sevoflurane-induced emergence agitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Yeditepe University Hospital | Conditions: Emergence Agitation | Phase 4 | Status: COMPLETED